I totally agree. Only talking ALS/MND negotiations.
And, life becomes much easier for the Go To Market strategy if Relyvrio is removed.
No convincing physicians and their patients to move to MPL vs Relyvrio .... there will be no choice.
Market share - 100%
Value just increased significantly .... market share / rate of adoption taken out of negotiation conversation.
I totally agree. Only talking ALS/MND negotiations.And, life...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23280 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 447 | 1 |
View Market Depth
| Last trade - 09.58am 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.5¢ |
Change
0.000 ( 4.40 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 19.0¢ | 18.0¢ | 264842 | ||
| Last updated 10.19am 14/05/2024 ? | |||||
| PAA (ASX) Chart |
Day chart unavailable